V-Square Quantitative Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

V-Square Quantitative Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.5K	Sell	394 -403	-51%	-$22.1K	﹤0.01%	703
2026 Q1	$45K	Buy	797 +44	+6%	+$2.56K	﹤0.01%	601
2025 Q4	$44.8K	Buy	+753	New	+$41K	﹤0.01%	586
2025 Q3	–	Sell	-450	Closed	-$24.7K	–	208
2025 Q2	$24.7K	Buy	+450	New	+$26.5K	﹤0.01%	586

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

V-Square Quantitative Management's BMRN Position: Q2 2026 in Review

V-Square Quantitative Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 51% in Q2 2026, selling an estimated $22.1K and leaving 394 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

V-Square Quantitative Management first reported a position in BMRN in Q2 2025 and has held it in 4 quarters since. The position peaked at $45K in Q1 2026. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

V-Square Quantitative Management held 394 shares of BioMarin Pharmaceuticals worth $22.5K as of Q2 2026.
V-Square Quantitative Management sold 403 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $22.1K.
BioMarin Pharmaceuticals made up ﹤0.01% of V-Square Quantitative Management's portfolio in Q2 2026, its #703 holding.
V-Square Quantitative Management first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
V-Square Quantitative Management's BioMarin Pharmaceuticals position peaked at $45K in Q1 2026.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.